Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Liquid Biopsy as a Tool to Evaluate Resistance to First and Third (AZD9291) (EGFR) (TKIs) in (EGFR) Mutant NSCLC

Hellenic Oncology Research Group · 2016
ClinicalTrials.gov · Datasets · License: Public Domain · 2016
Open Source ↗
liquidbiopsynsclc
non small cell lung cancer, nsclc, azd9291, >= 2nd line, liquid biopsy, egfr tkis, egfr mutant, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 914842
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.